Noven Pharmaceuticals Inc. Names Steven M. Dinh Vice President and Chief Scientific Officer

MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the appointment of Steven M. Dinh to the newly created position of Vice President and Chief Scientific Officer. In this role, Dinh will be responsible for the functioning, expansion and productivity of Noven’s transdermal drug delivery program and related transdermal product development activities.

Back to news